Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Coding Long COVID: Characterizing a new disease through an ICD-10 lens

View ORCID ProfileEmily R Pfaff, View ORCID ProfileCharisse Madlock-Brown, John M. Baratta, Abhishek Bhatia, Hannah Davis, Andrew Girvin, Elaine Hill, Liz Kelly, Kristin Kostka, Johanna Loomba, Julie A. McMurry, Rachel Wong, View ORCID ProfileTellen D Bennett, Richard Moffitt, Christopher G Chute, Melissa Haendel, The N3C Consortium, The RECOVER Consortium
doi: https://doi.org/10.1101/2022.04.18.22273968
Emily R Pfaff
1University of North Carolina at Chapel Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily R Pfaff
  • For correspondence: epfaff@email.unc.edu
Charisse Madlock-Brown
2University of Tennessee Health Science Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charisse Madlock-Brown
John M. Baratta
1University of North Carolina at Chapel Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Bhatia
1University of North Carolina at Chapel Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Davis
3Patient-Led Research Collaborative
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Girvin
4Palantir Technologies
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Hill
5University of Rochester
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liz Kelly
1University of North Carolina at Chapel Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Kostka
6Northeastern University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Loomba
7University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie A. McMurry
8University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Wong
9Stony Brook University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tellen D Bennett
8University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tellen D Bennett
Richard Moffitt
9Stony Brook University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher G Chute
10Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Haendel
8University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Naming a newly discovered disease is always challenging; in the context of the COVID-19 pandemic and the existence of post-acute sequelae of SARS-CoV-2 infection (PASC), which includes Long COVID, it has proven especially challenging. Disease definitions and assignment of a diagnosis code are often asynchronous and iterative. The clinical definition and our understanding of the underlying mechanisms of Long COVID are still in flux. The deployment of an ICD-10-CM code for Long COVID in the US took nearly two years after patients had begun to describe their condition. Here we leverage the largest publicly available HIPAA-limited dataset about patients with COVID-19 in the US to examine the heterogeneity of adoption and use of U09.9, the ICD-10-CM code for “Post COVID-19 condition, unspecified.”

Our results include a characterization of common diagnostics, treatment-oriented procedures, and medications associated with U09.9-coded patients, which give us insight into current practice patterns around Long COVID. We also established the diagnoses most commonly co-occurring with U09.9, and algorithmically clustered them into three major categories: cardiopulmonary, neurological, and metabolic. We aim to apply the patterns gleaned from this analysis to flag probable Long COVID cases occurring prior to the existence of U09.9, thus establishing a mechanism to ensure patients with earlier cases of Long-COVID are no less ascertainable for current and future research and treatment opportunities.

Competing Interest Statement

AT Girvin is an employee of Palantir Technologies. MA Haendel and JA McMurry are co-founders of Pryzm Health.

Funding Statement

This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH. All authors are funded under this mechanism.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The IRBs of the University of North Carolina at Chapel Hill, University of Tennessee Health Science Center, University of Rochester, Northeastern University, University of Virginia, University of Colorado, Stony Brook University, and Johns Hopkins University gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • (co-first)

Data Availability

The N3C data transfer to NCATS is performed under a Johns Hopkins University Reliance Protocol # IRB00249128 or individual site agreements with NIH. The N3C Data Enclave is managed under the authority of the NIH; information can be found at ncats.nih.gov/n3c/resources. Enclave data is protected, and can be accessed for COVID-related research with an approved (1) IRB protocol and (2) Data Use Request (DUR). Enclave and data access instructions can be found at https://covid.cd2h.org/for-researchers; all code used to produce the analyses in this manuscript is available within the N3C Enclave to users with valid login credentials to support reproducibility.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 19, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Coding Long COVID: Characterizing a new disease through an ICD-10 lens
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Coding Long COVID: Characterizing a new disease through an ICD-10 lens
Emily R Pfaff, Charisse Madlock-Brown, John M. Baratta, Abhishek Bhatia, Hannah Davis, Andrew Girvin, Elaine Hill, Liz Kelly, Kristin Kostka, Johanna Loomba, Julie A. McMurry, Rachel Wong, Tellen D Bennett, Richard Moffitt, Christopher G Chute, Melissa Haendel, The N3C Consortium, The RECOVER Consortium
medRxiv 2022.04.18.22273968; doi: https://doi.org/10.1101/2022.04.18.22273968
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Coding Long COVID: Characterizing a new disease through an ICD-10 lens
Emily R Pfaff, Charisse Madlock-Brown, John M. Baratta, Abhishek Bhatia, Hannah Davis, Andrew Girvin, Elaine Hill, Liz Kelly, Kristin Kostka, Johanna Loomba, Julie A. McMurry, Rachel Wong, Tellen D Bennett, Richard Moffitt, Christopher G Chute, Melissa Haendel, The N3C Consortium, The RECOVER Consortium
medRxiv 2022.04.18.22273968; doi: https://doi.org/10.1101/2022.04.18.22273968

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1425)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (585)
  • Epidemiology (10307)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2637)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1740)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (268)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1327)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (238)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2405)
  • Public and Global Health (5018)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)